跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 373 条关于
“lutetium vipivotide tetraxetan”
全部
373
临床试验
137
药物
91
机构
0
资讯
145
去年
Lutetium Lu 177 Vipivotide Tetraxetan Shows Promise in Prostate Cancer Treatment
3年前
FDA Approves Lutetium Lu 177 Vipivotide Tetraxetan for PSMA-Positive Metastatic Castration-Resistant Prostate Cancer
去年
Telix's Illuccix Receives Expanded Approval in Australia and Canada for PSMA-Targeted Therapy Selection
2年前
Eli Lilly's Lutetium Zadavotide Guraxetan Shows Promise in Metastatic Castration-Resistant Prostate Cancer
去年
Advances in Metastatic Prostate Cancer Treatment: Avenues for Extending Survival
去年
177Lu-PSMA-I&T Demonstrates rPFS Benefit in mCRPC Patients in ECLIPSE Trial
去年
Blue Earth Therapeutics Secures $76.5M to Advance PSMA-Targeted Radioligand Therapies
去年
Radiopharmaceuticals Reshape Cancer Treatment Landscape: From Thyroid to Advanced Prostate Cancer
7个月前
PYLARIFY Becomes First Blockbuster Radiodiagnostic with $1.06 Billion in 2024 Sales
去年
Novel AR Degraders and Emerging Therapies Show Promise in Advanced Prostate Cancer Treatment
第 1 页，共 15 页
上一页
下一页
